Simple Summary Researchers have shown that tumor biomarkers and increased nerve
density are important clinical tools for determining cancer prognosis and developing …

Stathmin has been investigated to be involved in development and progress of malignant
tumors. This study was to clarify the relationship between expression of stathmin and tumors …

Merkel cell carcinoma (MCC) is an aggressive skin cancer of neuroendocrine origin with a
high propensity for recurrence and metastasis. Merkel cell polyomavirus (MCPyV) causes …

Tumor metastasis is the main cause of death in advanced colorectal cancer. Our previous
research showed that upregulation of KIAA1199 predicted poorer outcomes, and promoted …

Microtubule‐targeting agents represent one of the most successful classes of anticancer
agents. However, the development of drug resistance and the appearance of adverse effects …

Sulforaphane (SFN) inhibited growth in many cancers, but its half-life is 2 h in circulation.
However, its metabolites, sulforaphane-cysteine (SFN-Cys) and sulforaphane-N-acetyl …

Sorafenib (SFB) is an anticancer drug with sparingly water solubility and reduced
bioavailability. Nanoformulation of SFB can increase its dissolution rate and solubility. The …

Glioblastoma multiforme (GBM) is characterized by highly invasive growth, which leads to
extensive infiltration and makes complete tumor excision difficult. Since cytoskeleton …

Our previous studies have identified that silencing oncoprotein 18 (Op18)/stathmin via RNA
interference (RNAi) inhibited autocrine interleukin‑10 (IL‑10) and enhanced the sensitivity to …

Background Stathmin is a ubiquitous cytosolic regulatory phosphoprotein and is
overexpressed in different human malignancies. The main physiological function of stathmin …